Udho Thadani to Calcium Channel Blockers
                            
                            
                                This is a "connection" page, showing publications Udho Thadani has written about Calcium Channel Blockers.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.086
         
        
        
     
 
    
        
        - 
            Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris. Am Heart J. 2002 Jul; 144(1):8-10.
            
            
                Score: 0.193
             
- 
            Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart Dis. 1999 Nov-Dec; 1(5):279-88.
            
            
                Score: 0.161
             
- 
            Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30.
            
            
                Score: 0.135
             
- 
            A multicenter comparison of isradipine and prazosin for treatment of essential hypertension. Cardiovasc Drugs Ther. 1990 Apr; 4(2):413-7.
            
            
                Score: 0.083
             
- 
            Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3.
            
            
                Score: 0.073
             
- 
            Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114.
            
            
                Score: 0.071
             
- 
            Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.
            
            
                Score: 0.064
             
- 
            Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C.
            
            
                Score: 0.058
             
- 
            Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9.
            
            
                Score: 0.050
             
- 
            Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf. 1998 Jul; 19(1):23-44.
            
            
                Score: 0.037
             
- 
            Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol. 1997 Jun 26; 79(12B):24-30.
            
            
                Score: 0.034
             
- 
            Chronic stable angina pectoris. Strategies for effective drug therapy. Postgrad Med. 1995 Dec; 98(6):175-6, 179-83, 187-8.
            
            
                Score: 0.031
             
- 
            Nitrates for unstable angina. Cardiovasc Drugs Ther. 1994 Oct; 8(5):719-26.
            
            
                Score: 0.028
             
- 
            Mononitrates: defining the ideal long-acting nitrate. Clin Ther. 1994 Mar-Apr; 16(2):130-9; discussion 129.
            
            
                Score: 0.027
             
- 
            Medical therapy of stable angina pectoris. Cardiol Clin. 1991 Feb; 9(1):73-87.
            
            
                Score: 0.022
             
- 
            Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135.
            
            
                Score: 0.020